Loading...
171: ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC).
Lawless, C Landau, D Faivre-Finn, Corinne Boyd, K Lester, J Fenwick, J Maguire, J Mccartney, E Paul, J Parsons, E
Lawless, C
Landau, D
Faivre-Finn, Corinne
Boyd, K
Lester, J
Fenwick, J
Maguire, J
Mccartney, E
Paul, J
Parsons, E
Citations
Altmetric:
Abstract
Description
Date
2017-01
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
171: ADSCaN: a randomised phase II study of accelerated, dose escalated, sequential chemo-radiotherapy in non-small cell lung cancer (NSCLC). 2017, 103(suppl 1):S80-S81 Lung Cancer